Implantation of a left ventricular assist device in a patient with primary antiphospholipid syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18640348.
- Also identified by DOI 10.1016/j.athoracsur.2008.01.080.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The antiphospholipid syndrome is characterized by arterial and venous thrombosis and is associated with the presence of circulating antiphospholipid antibodies. Arterial thrombosis can result in myocardial infarction, which may potentially lead to end-stage heart failure. Here we report our anticoagulation protocol for patients with antiphospholipid syndrome that undergo axial-flow left ventricle assist devices (HeartMate II; Thoratec, Pleasanton, CA) implantation.
Medical subject headings
- Antiphospholipid Syndrome
- Heart Failure
- Heart-Assist Devices
- Prosthesis Implantation